fusion-antibodies
Northern Ireland, GB · Founded 2001 · 30 employees on LinkedIn · 1 known investors
Find your way into fusion-antibodies
Fusion Antibodies optimizes antibody development for research and therapeutic applications. The company serves pharmaceutical and biotech customers seeking to enhance antibody performance.
Investors · 1
Companies House · registry record
View on Companies House ↗- Registered name
- FUSION ANTIBODIES PLC
- Company number
- NI039740
- Status
- Active
- Company type
- Public limited company
- Incorporated
- 29 Nov 2000
- Registered office
- 1 Springbank Road, Springbank Industrial Estate, Belfast, BT17 0QL
- Nature of business (SIC)
- 72110 — Research and experimental development on biotechnology74909 — Other professional, scientific and technical activities n.e.c.
- Previous names
- FUSION ANTIBODIES LIMITED (2000–2017)
- Accounts
- last made up to 31 Mar 2025 · next due 30 Sept 2026
- Confirmation statement
- last made up to 20 Jan 2026 · next due 3 Feb 2027
Current officers · 7
- Stephen Barry Smyth — secretary, appointed 16 Sept 2023
- Matthew Paul Baker — director, appointed 1 Mar 2022
- Richard Buick — director, appointed 15 Aug 2011
- Simon Gordon Douglas — director, appointed 7 Sept 2006
- Adrian Robert Kinkaid — director, appointed 25 Aug 2022
- Stephen Barry Smyth — director, appointed 13 Sept 2023
- Colin James Walsh — director, appointed 3 Jul 2007
Source: Companies House public register · retrieved 13 Sept 2026. Contains public sector information licensed under the Open Government Licence v3.0.
Frequently asked questions
- What does fusion-antibodies do?
- Fusion Antibodies optimizes antibody development for research and therapeutic applications. The company serves pharmaceutical and biotech customers seeking to enhance antibody performance.
- Who are fusion-antibodies's investors?
- fusion-antibodies's investors include Clarendon Fund Managers Ltd..
- Where is fusion-antibodies headquartered?
- fusion-antibodies is headquartered in Northern Ireland, GB.